Compounded semaglutide is a reality of the current GLP-1 landscape. Insurance denials, supply shortages, and cost barriers push many people toward compounding pharmacies. This article isn't here to judge that decision. It's here to help you do it safely.
What "compounded" means.
Compounding pharmacies create custom medications by mixing raw ingredients. Compounded semaglutide uses the same active molecule as Ozempic/Wegovy, but:
- It's not manufactured by Novo Nordisk
- It hasn't undergone FDA's standard approval process
- Quality control varies significantly between pharmacies
- The formulation (inactive ingredients, concentration, sterility) may differ
The FDA's position.
The FDA has issued multiple warnings about compounded semaglutide:
- Sterility concerns: Over 15,000 vials recalled across multiple pharmacies for sterility failures
- Dosing accuracy: Some compounded products contained more or less semaglutide than labeled
- Salt form differences: Some compounded versions use semaglutide sodium salt rather than the base form, which may affect dosing
- Adverse event reports: The FDA has received reports of adverse events from compounded versions
How to reduce risk.
If you choose compounded GLP-1:
Verify the pharmacy:
- Check state board of pharmacy licensing
- Look for accreditation from PCAB (Pharmacy Compounding Accreditation Board)
- 503B outsourcing facilities are held to higher standards than 503A pharmacies
- Ask for certificates of analysis (COA) for potency and sterility
Monitor yourself:
- Track side effects carefully. Unusual reactions may signal quality issues
- Watch for inconsistent effects dose-to-dose (may indicate potency variation)
- Keep records of lot numbers
Red flags:
- Prices significantly below market (too good to be true)
- No prescription required
- No pharmacist available for questions
- Won't provide certificates of analysis
The insurance reality.
Many users arrive at compounded semaglutide after losing insurance coverage or being denied authorization. Some describe trying compounded versions after successful treatment with branded medication and finding the results inconsistent: similar side effects but less appetite suppression.
This is consistent with the quality variation the FDA has documented. Compounded is not inherently dangerous, but it's not equivalent to FDA-approved products.
Alternatives to explore.
Before choosing compounded:
- Manufacturer savings programs: Novo Nordisk and Lilly both offer patient assistance
- GoodRx and similar discount cards: can significantly reduce cost
- Insurance appeals: denials can often be reversed with documentation from your doctor
- Alternative FDA-approved medications: liraglutide (Saxenda) may have different coverage
Sources
This article is for educational purposes only and is not medical advice. Always consult your healthcare provider about medication safety.